Approval for Pfizer, Moderna Covid-19 vaccines under consideration: Govt
Premium
(HT PRINT)
Read Full Story
The central government is in discussions with American pharmaceutical companies Pfizer and Moderna over their Covid-19 vaccines, said Dr VK Paul, member (health) of Niti Aayog. Approval to Pfizer and Moderna is under consideration, Paul said.
MORE FROM THIS SECTIONSee All
Premium Premium
Premium Premium
Premium Premium
Premium Premium
He informed that Pfizer has indicated its vaccines will likely be available in July.
This comes a day after government officials stated that if India enters into procurement deals with Pfizer, Moderna and J&J, then the vaccine supply will be further boosted. This will help the country realise its target of inoculating all adults by the end of the year.
The final agreement between the government and the American drug-maker on indemnity and procurement norms are still pending, though the two parties have arrived at an in-principle consensus, sources said.
Read more about Govt exploring local manufacturing of Pfizer, J&J, Moderna vaccines: MEA on Business Standard. "We have also helped expedite the introduction of Sputnik-V vaccines," the external affairs ministry spokesperson Arindam Bagchi told ANI.
DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines
Vaccines which have been approved by select regulatory bodies will not need to conduct bridging trials, the country s apex drug regulator said on Tuesday.
Vials labelled Moderna, Johnson & Johnson, Pfizer-BioNTech COVID-19 vaccine are seen in this illustration. Photo: ReutersS/Dado Ruvic
Health6 hours ago
New Delhi: In a move that is expected to smooth Pfizer and Moderna’s entry into the market, India’s top drug regulator on Tuesday exempted foreign-made COVD-19 vaccines from post-approval bridging trials in the country, if they are approved by certain health bodies.
Indian Express, companies such as Pfizer and Cipla have asked for these exemptions during negotiations to supply vaccines to the country. However, there does not seem to be any update on Pfizer’s demand to grant indemnity â protecting it from any legal action if the vaccine leads to serious side effects, although an
The Union Health Ministry on Friday said that over 1.84 crore cases are currently available with the states and union territories. The ministry added that three lakh more will be delivered to them over the next three days.